Placebos PowerPoint PPT Presentations

All Time
Show:
Recommended
Sort by:
Use of Placebos in Controlled Trials PowerPoint PPT Presentation
Use of Placebos in Controlled Trials - There are a number of advantages to using a placebo that reduces non-selection bias. ... to harm (e.g. infection risk, anaesthesia) with no possibility of benefit. ...
There are a number of advantages to using a placebo that reduces non-selection bias. ... to harm (e.g. infection risk, anaesthesia) with no possibility of benefit. ...
| PowerPoint PPT presentation | free to download
The Power of Belief Complementary Therapies, Placebos and Healing PowerPoint PPT Presentation
The Power of Belief Complementary Therapies, Placebos and Healing - The Power of Belief Complementary Therapies, Placebos and Healing Gus Cairns www.guscairns.com Preparatory work Think of three adjectives that describe the kind of ...
The Power of Belief Complementary Therapies, Placebos and Healing Gus Cairns www.guscairns.com Preparatory work Think of three adjectives that describe the kind of ...
| PowerPoint PPT presentation | free to download
Placebos and Painkillers: Is Mind as Real as Matter? Luana Colloca and Fabrizio Benedetti 2005 in Nature Reviews Neuroscience PowerPoint PPT Presentation
Placebos and Painkillers: Is Mind as Real as Matter? Luana Colloca and Fabrizio Benedetti 2005 in Nature Reviews Neuroscience - This is a mechanism working on the cognitive aspects of therapeutic outcome Pavlovian ... Opioid Reinforcement Through Dopamine Signaling ...
This is a mechanism working on the cognitive aspects of therapeutic outcome Pavlovian ... Opioid Reinforcement Through Dopamine Signaling ...
| PowerPoint PPT presentation | free to view
The Placebo Effect PowerPoint PPT Presentation
The Placebo Effect - T/F: There are no negative effects of placebos ... Sham surgeries. Inactive medical devices. Effective/non-effective acupuncture ...
T/F: There are no negative effects of placebos ... Sham surgeries. Inactive medical devices. Effective/non-effective acupuncture ...
| PowerPoint PPT presentation | free to download
Pediatric Research: Challenges for Institutional Review Boards PowerPoint PPT Presentation
Pediatric Research: Challenges for Institutional Review Boards - Define 'stable on medications' carefully. Careful assessment of drug holidays/placebos. If such a holiday would be reasonable in the clinical care of the patient ...
Define 'stable on medications' carefully. Careful assessment of drug holidays/placebos. If such a holiday would be reasonable in the clinical care of the patient ...
| PowerPoint PPT presentation | free to view
The Experimental procedure involves manipulating something called the Explanatory Variable and seein PowerPoint PPT Presentation
The Experimental procedure involves manipulating something called the Explanatory Variable and seein - Placebos: There is a proven phenomenon called the placebo effect. Patients receiving Placebo tablets which have no active ... Placebo effect. Hawthorne effect ...
Placebos: There is a proven phenomenon called the placebo effect. Patients receiving Placebo tablets which have no active ... Placebo effect. Hawthorne effect ...
| PowerPoint PPT presentation | free to download
Ethics in Testing PowerPoint PPT Presentation
Ethics in Testing - ... to read the article, Placebos break taboo in cancer drug tests: Study seeks hope ... http://www.irbforum.com/forum/read/2/78/78 ...
... to read the article, Placebos break taboo in cancer drug tests: Study seeks hope ... http://www.irbforum.com/forum/read/2/78/78 ...
| PowerPoint PPT presentation | free to download
Todo lo que necesitas saber sobre los ensayos clnicos PowerPoint PPT Presentation
Todo lo que necesitas saber sobre los ensayos clnicos - La comparaci n con un placebo puede ser la manera m s r pida y m s segura de ... No obstante, no se utilizan placebos cuando la ausencia de una terapia eficaz ...
La comparaci n con un placebo puede ser la manera m s r pida y m s segura de ... No obstante, no se utilizan placebos cuando la ausencia de una terapia eficaz ...
| PowerPoint PPT presentation | free to view
Ethical Issues in Pediatric Research: Placebo controlled trials for gastoesophogeal reflux PowerPoint PPT Presentation
Ethical Issues in Pediatric Research: Placebo controlled trials for gastoesophogeal reflux - Ethical Issues in Pediatric Research: Placebo controlled trials for gastoesophogeal reflux ... Department of Clinical Bioethics, Warren G Magnuson Clinical Center ...
Ethical Issues in Pediatric Research: Placebo controlled trials for gastoesophogeal reflux ... Department of Clinical Bioethics, Warren G Magnuson Clinical Center ...
| PowerPoint PPT presentation | free to view
Clinical Problem Solving Strategies PowerPoint PPT Presentation
Clinical Problem Solving Strategies - Clinical Problem Solving Strategies Placebo effects Placebo is Latin for I will please Refers to any type of treatment that is inert Used in research trials to ...
Clinical Problem Solving Strategies Placebo effects Placebo is Latin for I will please Refers to any type of treatment that is inert Used in research trials to ...
| PowerPoint PPT presentation | free to view
Ethical issues in the use of placebo control groups in water intervention trials UC Berkeley School PowerPoint PPT Presentation
Ethical issues in the use of placebo control groups in water intervention trials UC Berkeley School - 1. Ethical issues in the use of placebo control groups in water intervention trials ... would have no effect on the 25% of cases transmitted earlier in pregnancy) ...
1. Ethical issues in the use of placebo control groups in water intervention trials ... would have no effect on the 25% of cases transmitted earlier in pregnancy) ...
| PowerPoint PPT presentation | free to view
University of Utah PowerPoint PPT Presentation
University of Utah - The placebo effect an informative and entertaining BBC 4 audio production. http://badscience.net/files/Placebo BBC Radio 4 Ben Goldacre.mp3 ...
The placebo effect an informative and entertaining BBC 4 audio production. http://badscience.net/files/Placebo BBC Radio 4 Ben Goldacre.mp3 ...
| PowerPoint PPT presentation | free to view
Pr Jrme Palazzolo Psychiatre, Nice PowerPoint PPT Presentation
Pr Jrme Palazzolo Psychiatre, Nice - Pic d'activit : Habituellement plus pr coce que le m dicament actif. ... S'il existe un traitement actif sp cifique reconnu, Placebo impur la demande du patient ...
Pic d'activit : Habituellement plus pr coce que le m dicament actif. ... S'il existe un traitement actif sp cifique reconnu, Placebo impur la demande du patient ...
| PowerPoint PPT presentation | free to view
Selected Issues in Oncology Trial Design PowerPoint PPT Presentation
Selected Issues in Oncology Trial Design - 'Constancy assumption' ... Violating this assumption could lead to approval of 'toxic placebo' ... Non-informative censoring assumption. Which Events Count? ...
'Constancy assumption' ... Violating this assumption could lead to approval of 'toxic placebo' ... Non-informative censoring assumption. Which Events Count? ...
| PowerPoint PPT presentation | free to view
Touch and Pain PowerPoint PPT Presentation
Touch and Pain - Pacinian corpuscle detects sudden displacements or high-frequency vibrations on the skin ... placebo, drug with no effect, can relieve pain anesthesia ...
Pacinian corpuscle detects sudden displacements or high-frequency vibrations on the skin ... placebo, drug with no effect, can relieve pain anesthesia ...
| PowerPoint PPT presentation | free to view
DELAYEDSTART DESIGN WITH DOPAMINERGIC THERAPIES PowerPoint PPT Presentation
DELAYEDSTART DESIGN WITH DOPAMINERGIC THERAPIES - -CIT SPECT & Need for L-dopa. larger. Neuroimmu-nophilin A. NIL-A ... Enroll subjects with newly diagnosed PD, so that a placebo control group can be included. ...
-CIT SPECT & Need for L-dopa. larger. Neuroimmu-nophilin A. NIL-A ... Enroll subjects with newly diagnosed PD, so that a placebo control group can be included. ...
| PowerPoint PPT presentation | free to view
Hyperbaric Medicine Treatment or Placebo PowerPoint PPT Presentation
Hyperbaric Medicine Treatment or Placebo - Hyperbaric Medicine Treatment or Placebo
Hyperbaric Medicine Treatment or Placebo
| PowerPoint PPT presentation | free to view
The Size, Scope and Implications of Placebo and Active Controlled Trials PowerPoint PPT Presentation
The Size, Scope and Implications of Placebo and Active Controlled Trials - The Size, Scope and Implications of Placebo and Active Controlled Trials ... Sample sizes for trials with BMD and vertebral fracture outcomes ...
The Size, Scope and Implications of Placebo and Active Controlled Trials ... Sample sizes for trials with BMD and vertebral fracture outcomes ...
| PowerPoint PPT presentation | free to view
Hyponatremia And treatment with tolvaptan PowerPoint PPT Presentation
Hyponatremia And treatment with tolvaptan - UZMA MEHDI, M.D, MS NEPHROLOGY SALT Trial Pt were randomly assigned to placebo vs 15mg of tolvaptan Dose of tolvaptan was increased to 30mg and then to 60mg if necessary.
UZMA MEHDI, M.D, MS NEPHROLOGY SALT Trial Pt were randomly assigned to placebo vs 15mg of tolvaptan Dose of tolvaptan was increased to 30mg and then to 60mg if necessary.
| PowerPoint PPT presentation | free to download
CHARM Program: 3 Component trials comparing candesartan with placebo PowerPoint PPT Presentation
CHARM Program: 3 Component trials comparing candesartan with placebo - Title: PowerPoint Presentation Author: William Tryon Created Date: 1/9/2003 10:52:48 PM Document presentation format: On-screen Show Other titles
Title: PowerPoint Presentation Author: William Tryon Created Date: 1/9/2003 10:52:48 PM Document presentation format: On-screen Show Other titles
| PowerPoint PPT presentation | free to view
Pharmacogenetics and Pharmacogenomics PowerPoint PPT Presentation
Pharmacogenetics and Pharmacogenomics - Pharmacogenetics and Pharmacogenomics Kevin Zbuk, MD Medical Oncologist Juravinski Cancer Centre McMaster University Effect of Clopidogrel as Compared with Placebo on ...
Pharmacogenetics and Pharmacogenomics Kevin Zbuk, MD Medical Oncologist Juravinski Cancer Centre McMaster University Effect of Clopidogrel as Compared with Placebo on ...
| PowerPoint PPT presentation | free to download
Practical Approach to Acute Gastrointestinal Bleeding PowerPoint PPT Presentation
Practical Approach to Acute Gastrointestinal Bleeding - Patients with ulcers requiring endoscopic therapy should receive PPI gtt x 72 hours Significantly reduces 30 day rebleeding rate vs placebo (6.7% vs. 22.5%) ...
Patients with ulcers requiring endoscopic therapy should receive PPI gtt x 72 hours Significantly reduces 30 day rebleeding rate vs placebo (6.7% vs. 22.5%) ...
| PowerPoint PPT presentation | free to download
Ductal Carcinoma In Situ (DCIS) PowerPoint PPT Presentation
Ductal Carcinoma In Situ (DCIS) - ... Radiotherapy, and Tamoxifen; or Excision, Radiotherapy, and Placebo. The overall risk, the risk of invasive cancer, and the risk of noninvasive cancer are shown.
... Radiotherapy, and Tamoxifen; or Excision, Radiotherapy, and Placebo. The overall risk, the risk of invasive cancer, and the risk of noninvasive cancer are shown.
| PowerPoint PPT presentation | free to download
UPDATE%20ON%20ANTIPLATELET%20THERAPY%20IN%20THE%20TREATMENT%20AND%20PREVENTION%20OF%20CARDIOVASCULAR%20DISEASE PowerPoint PPT Presentation
UPDATE%20ON%20ANTIPLATELET%20THERAPY%20IN%20THE%20TREATMENT%20AND%20PREVENTION%20OF%20CARDIOVASCULAR%20DISEASE - ... placebo-controlled trials show that both PPIs and histamine-2 receptor antagonists decrease the development of endoscopic ulcers in low-dose aspirin ... CABG ...
... placebo-controlled trials show that both PPIs and histamine-2 receptor antagonists decrease the development of endoscopic ulcers in low-dose aspirin ... CABG ...
| PowerPoint PPT presentation | free to download
Comparing Groups PowerPoint PPT Presentation
Comparing Groups - Load the Generalized Anxiety Disorder (GAD) data. It has Hamilton Rating Scale for Anxiety data for people taking placebo, high or low dose drug.
Load the Generalized Anxiety Disorder (GAD) data. It has Hamilton Rating Scale for Anxiety data for people taking placebo, high or low dose drug.
| PowerPoint PPT presentation | free to download
Antiarrhythmic Drugs for Shock-Refractory PowerPoint PPT Presentation
Antiarrhythmic Drugs for Shock-Refractory - Antiarrhythmic Drugs for Shock-Refractory . Out-of-Hospital Cardiac Arrest: The Amiodarone, Lidocaine or Placebo Study (ALPS) Dallas. Portland. Alabama
Antiarrhythmic Drugs for Shock-Refractory . Out-of-Hospital Cardiac Arrest: The Amiodarone, Lidocaine or Placebo Study (ALPS) Dallas. Portland. Alabama
| PowerPoint PPT presentation | free to download
Immunonutrition in the Critically Ill? Role of Arginine-supplemented diets PowerPoint PPT Presentation
Immunonutrition in the Critically Ill? Role of Arginine-supplemented diets - Specific nutrients found to have effects on immune system, ... Beagles. Parenteral L-arginine ( NAC) vs placebo. Canine model of E. coli peritonitis ...
Specific nutrients found to have effects on immune system, ... Beagles. Parenteral L-arginine ( NAC) vs placebo. Canine model of E. coli peritonitis ...
| PowerPoint PPT presentation | free to download
Presentazione di PowerPoint PowerPoint PPT Presentation
Presentazione di PowerPoint - ... 353: 2121-34 Effect of Placebo or 20 mg of Rimonabant for 52 Weeks on the Plasma Glucose and Insulin Responses to Oral Glucose Challenge (Panels A - B), ...
... 353: 2121-34 Effect of Placebo or 20 mg of Rimonabant for 52 Weeks on the Plasma Glucose and Insulin Responses to Oral Glucose Challenge (Panels A - B), ...
| PowerPoint PPT presentation | free to download
The Science of Psychology PowerPoint PPT Presentation
The Science of Psychology - The Science of Psychology Chapter 1 Menu LO 1.11 Experimental approach and terms The Experiment The Experiment Placebo effect - the phenomenon in which the ...
The Science of Psychology Chapter 1 Menu LO 1.11 Experimental approach and terms The Experiment The Experiment Placebo effect - the phenomenon in which the ...
| PowerPoint PPT presentation | free to download
Asthma Trial PowerPoint PPT Presentation
Asthma Trial - Asthma Trial a double blinded, randomized, placebo-controlled study Team Moser: Jing Dong Yan Yan Wu Haipeng Yao Purpose The new puffer is effective or not Target ...
Asthma Trial a double blinded, randomized, placebo-controlled study Team Moser: Jing Dong Yan Yan Wu Haipeng Yao Purpose The new puffer is effective or not Target ...
| PowerPoint PPT presentation | free to view
JUPITER Primary Trial End Point: PowerPoint PPT Presentation
JUPITER Primary Trial End Point: - JUPITER Primary Trial End Point: MI, Stroke, UA/Revascularization, CV Death Placebo 251/8901 0.08 HR 0.56, 95% CI 0.46-0.69 P
JUPITER Primary Trial End Point: MI, Stroke, UA/Revascularization, CV Death Placebo 251/8901 0.08 HR 0.56, 95% CI 0.46-0.69 P
| PowerPoint PPT presentation | free to download
Education for Sustainable Development: PowerPoint PPT Presentation
Education for Sustainable Development: - Education for Sustainable Development: Cure or Placebo? David V. J. Bell, PhD (dvjbell@rogers.com) Professor Emeritus and Former Dean, Faculty of Environmental Studies,
Education for Sustainable Development: Cure or Placebo? David V. J. Bell, PhD (dvjbell@rogers.com) Professor Emeritus and Former Dean, Faculty of Environmental Studies,
| PowerPoint PPT presentation | free to view
Aromatherapy With Peppermint , Isopropyl Alcohol or Placebo is Equally Effective in Relieving Postoperative Nausea PowerPoint PPT Presentation
Aromatherapy With Peppermint , Isopropyl Alcohol or Placebo is Equally Effective in Relieving Postoperative Nausea - Aromatherapy With Peppermint , Isopropyl Alcohol or Placebo is Equally Effective in Relieving Postoperative Nausea Lynn AA, Jeffrey GB (2004) Postoperative nausea and ...
Aromatherapy With Peppermint , Isopropyl Alcohol or Placebo is Equally Effective in Relieving Postoperative Nausea Lynn AA, Jeffrey GB (2004) Postoperative nausea and ...
| PowerPoint PPT presentation | free to view
EMBRACE STEMI PowerPoint PPT Presentation
EMBRACE STEMI - EMBRACE STEMI A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability, and efficacy of intravenous Bendavia on reperfusion ...
EMBRACE STEMI A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability, and efficacy of intravenous Bendavia on reperfusion ...
| PowerPoint PPT presentation | free to download
Merci pour votre invitation PowerPoint PPT Presentation
Merci pour votre invitation - This finding is compatible with the notion that the clinical effects of homoeopathy are placebo effects Diapositive 28 Science / Anti-science ?
This finding is compatible with the notion that the clinical effects of homoeopathy are placebo effects Diapositive 28 Science / Anti-science ?
| PowerPoint PPT presentation | free to download
Hydroxycut, Proof or Placebo? PowerPoint PPT Presentation
Hydroxycut, Proof or Placebo? - Hydroxycut is a clear example of the money that ... Hydroxycut. Thermogenic compund- aids your body in burning more fat by ... proves Hydroxycut to be ...
Hydroxycut is a clear example of the money that ... Hydroxycut. Thermogenic compund- aids your body in burning more fat by ... proves Hydroxycut to be ...
| PowerPoint PPT presentation | free to download
TRANSCEND: Telmisartan Randomized AssesmeNt Study in aCE iNtolerant Subjects with Cardiovascular Disease PowerPoint PPT Presentation
TRANSCEND: Telmisartan Randomized AssesmeNt Study in aCE iNtolerant Subjects with Cardiovascular Disease - Is telmisartan superior to placebo in patients at high risk of CV ... Concomitant Medications. by Visit (%) Baseline. Year 2. Final. Tel Pl. Tel. Pl. Tel. Pl ...
Is telmisartan superior to placebo in patients at high risk of CV ... Concomitant Medications. by Visit (%) Baseline. Year 2. Final. Tel Pl. Tel. Pl. Tel. Pl ...
| PowerPoint PPT presentation | free to view
Prophylaxis in Crohns disease after surgical intervention PowerPoint PPT Presentation
Prophylaxis in Crohns disease after surgical intervention - Ornidazole 1 g/day or placebo continued for 1 year within 1week of resection ... should be considered as a maintenance therapy after ileocolic resection ...
Ornidazole 1 g/day or placebo continued for 1 year within 1week of resection ... should be considered as a maintenance therapy after ileocolic resection ...
| PowerPoint PPT presentation | free to view
Epoetin beta in the Treatment of Anemia in Cancer Patients PowerPoint PPT Presentation
Epoetin beta in the Treatment of Anemia in Cancer Patients - 53% smokers in placebo vs. 66% in epoetin beta group. Relapse at baseline ... Smoker. Non-smoker. Baseline Hb 11 g/dL. Baseline Hb 11g/dL. Category. Subgroup. 0.2 ...
53% smokers in placebo vs. 66% in epoetin beta group. Relapse at baseline ... Smoker. Non-smoker. Baseline Hb 11 g/dL. Baseline Hb 11g/dL. Category. Subgroup. 0.2 ...
| PowerPoint PPT presentation | free to view
John H. Alexander, MD, MS, FACC PowerPoint PPT Presentation
John H. Alexander, MD, MS, FACC - A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk Coronary Artery ...
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk Coronary Artery ...
| PowerPoint PPT presentation | free to view
Health Research PowerPoint PPT Presentation
Health Research - Health Research What is the placebo effect? An expectation of an effect gives that effect. What can increase the placebo effect? Big pills - not little ones Colored ...
Health Research What is the placebo effect? An expectation of an effect gives that effect. What can increase the placebo effect? Big pills - not little ones Colored ...
| PowerPoint PPT presentation | free to view
SGRQ PowerPoint PPT Presentation
SGRQ - ... Tiotropium Placebo Salmeterol Trough FEV1: 0.029L -0.056L 0.038L TDI responders Tiotropium Placebo Salmeterol Trough FEV1: 0.107L 0 ...
... Tiotropium Placebo Salmeterol Trough FEV1: 0.029L -0.056L 0.038L TDI responders Tiotropium Placebo Salmeterol Trough FEV1: 0.107L 0 ...
| PowerPoint PPT presentation | free to view
Summary of Design PowerPoint PPT Presentation
Summary of Design - Summary of Design Aim: Effect of Ramipril (up to 10mg/d) or Vit E (400 IU/d) vs its placebo on CV death, M I or stroke (primary) Design: Randomized double blind, 2x2 ...
Summary of Design Aim: Effect of Ramipril (up to 10mg/d) or Vit E (400 IU/d) vs its placebo on CV death, M I or stroke (primary) Design: Randomized double blind, 2x2 ...
| PowerPoint PPT presentation | free to download
Genitourinary%20Oncology:%20Prostate%20and%20Renal%20Cancer PowerPoint PPT Presentation
Genitourinary%20Oncology:%20Prostate%20and%20Renal%20Cancer - For cause or surgery: End of study biopsy: Total. Finasteride Placebo. 1523 1511 ... Correlates with risk of aggressive prostate cancer, but is a continuous, not a ...
For cause or surgery: End of study biopsy: Total. Finasteride Placebo. 1523 1511 ... Correlates with risk of aggressive prostate cancer, but is a continuous, not a ...
| PowerPoint PPT presentation | free to download
Leflunomida (ARAVA?) PowerPoint PPT Presentation
Leflunomida (ARAVA?) - ECA que comparen leflunomida con placebo u ... (MEDLINE, Aventis) Leflunomida vs placebo (y SZP). 358 pac, 6 meses (Smolen et al. Lancet 1999) ... (MEDLINE) ...
ECA que comparen leflunomida con placebo u ... (MEDLINE, Aventis) Leflunomida vs placebo (y SZP). 358 pac, 6 meses (Smolen et al. Lancet 1999) ... (MEDLINE) ...
| PowerPoint PPT presentation | free to download
La buena adherencia a la medicaci PowerPoint PPT Presentation
La buena adherencia a la medicaci - ... de que esta relaci n se d tambi n en el grupo placebo va a favor de que la buena adherencia sea un marcador de una conducta globalmente saludable.
... de que esta relaci n se d tambi n en el grupo placebo va a favor de que la buena adherencia sea un marcador de una conducta globalmente saludable.
| PowerPoint PPT presentation | free to view
Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-controlled Trials: The Cross Trial Safety Analysis PowerPoint PPT Presentation
Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-controlled Trials: The Cross Trial Safety Analysis - Cardiovascular Risk ... trial results led to stopping drug in that trial and in 5 ... or whether non-selective non-steroidal anti-inflammatory agents would be ...
Cardiovascular Risk ... trial results led to stopping drug in that trial and in 5 ... or whether non-selective non-steroidal anti-inflammatory agents would be ...
| PowerPoint PPT presentation | free to view
Major Lung Cancer Trials: PowerPoint PPT Presentation
Major Lung Cancer Trials: - Pemetrexed (vs. placebo) *HR 0.60, P
Pemetrexed (vs. placebo) *HR 0.60, P
| PowerPoint PPT presentation | free to download
EVALUATION OF EFFICACY OF PALONOSETRON VERSUS PLACEBO FOR PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING PowerPoint PPT Presentation
EVALUATION OF EFFICACY OF PALONOSETRON VERSUS PLACEBO FOR PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING - CO-AUTHORS Prof & HOD Dr.I.Chandrasekaran M.D.,D.A., Prof Dr.S.P.Meenakshisundaram M.D.,D.A., Asst. Prof Dr.D.S.Sudhakar M.D.,DNB., AUTHOR : G.N.Jeevanandam IIyr M.D. PG
CO-AUTHORS Prof & HOD Dr.I.Chandrasekaran M.D.,D.A., Prof Dr.S.P.Meenakshisundaram M.D.,D.A., Asst. Prof Dr.D.S.Sudhakar M.D.,DNB., AUTHOR : G.N.Jeevanandam IIyr M.D. PG
| PowerPoint PPT presentation | free to download
Time to First CHF Hospitalization for All Patients V-HeFT I, V-HeFT II PowerPoint PPT Presentation
Time to First CHF Hospitalization for All Patients V-HeFT I, V-HeFT II - DV Time to First CHF Hospitalization for All Patients V-HeFT I, V-HeFT II V-HeFT I V-HeFT II 100 100 Without hospitalization, % 90 90 80 80 70 70 ISDN/HYD Placebo
DV Time to First CHF Hospitalization for All Patients V-HeFT I, V-HeFT II V-HeFT I V-HeFT II 100 100 Without hospitalization, % 90 90 80 80 70 70 ISDN/HYD Placebo
| PowerPoint PPT presentation | free to download
IRA PowerPoint PPT Presentation
IRA - Aumento de la creatinina en 0,5 mg/dl en 48 hs con creatinina previa normal o ... ARF: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial ...
Aumento de la creatinina en 0,5 mg/dl en 48 hs con creatinina previa normal o ... ARF: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial ...
| PowerPoint PPT presentation | free to view


Home About Us Terms and Conditions Privacy Policy Contact Us
Copyright 2025 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
placebos — Search results on PowerShow.com